More Insight Into How a Virus Might Cause MS

09 Jan 2024
www.drugs.com
Clinical ResultClinical Study
MONDAY, Jan. 8, 2024 -- There's information emerging on how the common Epstein-Barr virus (EBV) might be crucial to triggering multiple sclerosis (MS).
The virus, which also causes "mono" (mononucleosis) and other illnesses, has gained prominence in recent years as a potential cause of MS. Over 95% of people are thought to carry EBV, although for most people it remains dormant.
Now, a team of Texan researchers report that certain immune cells targeted to EBV infection are found in high numbers in people newly diagnosed with MS.
The immune system cells are called T-cells, and they appear to be targeting lymphoblastoid cell lines (LCLs) infected with Epstein-Barr virus.
“This work demonstrates that T-cells specific for LCL are present in the cerebrospinal fluid at the earliest stages of [MS] disease,” said study senior author Dr. J. William Lindsey.
“This strongly suggests that these T-cells are either causing the disease or contributing to it in some way," said Lindsey, a professor of neurology at McGovern Medical School, UTHealth Houston.
"We have experiments in progress to define what these cells may be doing," he added in a UTHealth news release.
The study was published Jan. 8 in the Proceedings of the National Academy of Sciences.
EBV is a form of herpes virus that can be spread by bodily fluids, especially saliva. It's been strongly linked in recent years to MS, a chronic, debilitating illness of the central nervous system affecting millions.
Just how EBV might help trigger MS has remained a mystery. In the new study, Lindsey's team obtained samples of blood and cerebrospinal fluid from eight people midway through being diagnosed with MS.
They looked specifically at immune system T-cells within the cerebrospinal fluid samples, testing them to determine what pathogen or cell they might be sensitized to.
The answer: lymphoblastoid cell lines infected by EBV.
“This pattern was very different from what we observed in other neurologic diseases, suggesting it is unique to multiple sclerosis," said study lead author Assaf Gottlieb. He is an assistant professor with the Center for Precision Health, part of the McWilliams School of Biomedical Informatics at UTHealth Houston.
Overall, 13% of the T-cells in the cerebrospinal fluid of folks newly diagnosed with MS were sensitized to EBV-infected cells. That suggests a clear link between the activity of these T-cells and MS, the research team concluded.
T-cells sensitized for three other common infections were not present at above-normal levels in the fluid samples, the Texas group noted.
Sources
University of Texas Health Science Center at Houston, news release, Jan. 8, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.